Depression and Treatment with Effective Herbs

Author(s): Zohre Fathinezhad, Robert D.E Sewell, Zahra Lorigooini, Mahmoud Rafieian-Kopaei*

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 6 , 2019


Become EABM
Become Reviewer
Call for Editor

Abstract:

Depression is a common psychiatric disease and one of the main causes of disability worldwide. In spite of certain developments in this field, chemical and synthetic drugs used for the treatment of depression disrupt the treatment process due to numerous side effects and high cost. Today, the goal of using a potential method for treating depression involves the use of medicinal and phytochemical plants, which have many therapeutic benefits. Studies have shown that medicinal plants affect the nervous system and exert antidepressant effects in various ways, including synaptic regulation of serotonin, noradrenaline and dopamine, and inflammatory mediators. In this study, depression as well as the factors and mechanisms involved in its development are first addressed, and then medicinal plants effective in the treatment of depression along with their mechanisms of actions are reported.

Keywords: Depression, biomarkers, bio-factors, mechanism, medicinal plants, phytochemical plants.

[1]
Rahmati B, Kiasalari Z, Roghani M, Khalili M, Ansari F. Antidepressant and anxiolytic activity of Lavandula officinalis aerial parts hydroalcoholic extract in scopolamine-treated rats. Pharm Biol 2017; 55(1): 958-65.
[2]
Maria de Souza JM, Lira Ferrari GS, Bucalen Ferrari CK. Correlates of geriatric depression scale with perceived quality of life in an elderly population. Geriatr Persia 2018; 2e01
[3]
Rajput MS, Sinha S, Mathur V, Agrawal P. Herbal antidepressants. IJPFR 2011; 1(1): 159-69.
[4]
Noorbala AA, Akhondzadeh S, Tahmacebi-pour N, et al. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression : A double-blind, randomized pilot trial. J Ethnopharmacol 2005; 28; 97(2): 281-4.
[5]
Dwyer AV, Whitten DL, Hawrelak JA. Herbal medicines, other than St. John’s Wort, in the treatment of depression. Sci Rev Altern Med 2011; 16(1): 281-4.
[6]
Tegegne MT, Mossie TB, Awoke AA, Assaye AM, Gebrie BT, Eshetu DA. Depression and anxiety disorder among epileptic people at Amanuel Specialized Mental Hospital, Addis Ababa, Ethiopia. BMC Psychiatry 2015; 15(1): 210.
[7]
Rabiei Z, Rabie S. A review on antidepressant effect of medicinal plants. Bangladesh J Pharmacol 2017; 12(1): 1-1.
[8]
Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 2006; 7(2): 137-51.
[9]
Schulberg HC, Katon W, Simon GE, Rush AJ. Treating major depression in primary care practice: An update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry 1998; 55(12): 1121-7.
[10]
Drevets WC, Price ÆJL, Furey ML. Brain structural and functional abnormalities in mood disorders : implications for neurocircuitry models of depression. Funct 2008; 213(1-2): 93-118.
[11]
Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ III. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316(7): 363-9.
[12]
Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151(12): 1735-9.
[13]
Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34(1): 13-25.
[14]
Hindmarch I. Expanding the horizons of depression: beyond the monoamine hypothesis. Hum Psychopharmacol 2001; 16(3): 203-18.
[15]
Lee G, Bae H. Therapeutic effects of phytochemicals and medicinal herbs on depression. Bio Med Res Int 2017; 2017
[16]
Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci 1995; 18(1): 6-11.
[17]
Pan Y, Kong LD, Li YC, Xia X, Kung HF, Jiang FX. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol Biochem Behav 2007; 87(1): 130-40.
[18]
Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21(2): 293-307.
[19]
Menninger JA, Tabakoff B. Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with major depression. Biol Psychiatry 1997; 42(1): 30-8.
[20]
Pandya CD, Howell KR, Pillai A. Antioxidants as potential therapeutics for neuropsychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2013; 46: 214-23.
[21]
Maes M, Galecki P, Chang YS, Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35(3): 676-92.
[22]
Liu B, Xu C, Wu X, et al. Icariin exerts an antidepressant effect in an unpredictable chronic mild stress model of depression in rats and is associated with the regulation of hippocampal neuroinflammation. Neuroscience 2015; 294: 193-205.
[23]
Xing H, Zhang K, Zhang R, et al. Determination of depression biomarkers in rat plasma by liquid chromatography-mass spectrometry for the study of the antidepressant effect of Zhi-Zi-Hou-Po decoction on rat model of chronic unpredictable mild stress. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 988: 135-42.
[24]
Ladep NG, Obindo TJ, Audu MD, Okeke EN, Malu AO. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol 2006; 12(48): 7844-7.
[25]
Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol 2011; 21(12): 841-60.
[26]
Fekadu N, Shibeshi W, Engidawork E. Major depressive disorder: pathophysiology and clinical management. J Depress Anxiety 2016; 6(255): 2167-1044.
[27]
Novío S, Núñez MJ, Amigo G, Freire-Garabal M. Effects of fluoxetine on the oxidative status of peripheral blood leucocytes of restraint-stressed mice. Basic Clin Pharmacol Toxicol 2011; 109(5): 365-71.
[28]
Szafrański T. [Herbal remedies in depression--state of the art] Psychiatr Pol 2014; 48(1): 59-73.
[29]
Abdullaev FI, Espinosa-Aguirre JJ. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004; 28(6): 426-32.
[30]
Machado DG, Bettio LE, Cunha MP, et al. Antidepressant-like effect of rutin isolated from the ethanolic extract from Schinus molle L. in mice: evidence for the involvement of the serotonergic and noradrenergic systems. Eur J Pharmacol 2008; 587(1-3): 163-8.
[31]
Fajemiroye JO, da Silva DM, de Oliveira DR, Costa EA. Treatment of anxiety and depression: medicinal plants in retrospect. Fundam Clin Pharmacol 2016; 30(3): 198-215.
[32]
Martins JSB. Phytochemistry and pharmacology of anti-depressant medicinal plants: A review. Biomed Pharmacother 2018; 104: 343-65.
[33]
Cassani J, Ferreyra-Cruz OA, Dorantes-Barrón AM, Villaseñor RM, Arrieta-Baez D, Estrada-Reyes R. Antidepressant-like and toxicological effects of a standardized aqueous extract of Chrysactinia mexicana A. Gray (Asteraceae) in mice. J Ethnopharmacol 2015; 171: 295-306.
[34]
Yu L, Zhang Y, Ma R, Bao L, Fang J, Yu T. Potent protection of ferulic acid against excitotoxic effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain. Eur Neuropsychopharmacol 2006; 16(3): 170-7.
[35]
Takeda H, Tsuji M, Miyamoto J, Matsumiya T. Rosmarinic acid and caffeic acid reduce the defensive freezing behavior of mice exposed to conditioned fear stress. Psychopharmacology (Berl) 2002; 164(2): 233-5.
[36]
Zeni AL, Zomkowski AD, Maraschin M, Rodrigues AL, Tasca CI. Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system. Eur J Pharmacol 2012; 679(1-3): 68-74.
[37]
Yabe T, Hirahara H, Harada N, et al. Ferulic acid induces neural progenitor cell proliferation in vitro and in vivo. Neuroscience 2010; 165(2): 515-24.
[38]
Jäger AK, Saaby L. Flavonoids and the CNS. Molecules 2011; 16(2): 1471-85.
[39]
Saaby L, Rasmussen HB, Jäger AK. MAO-A inhibitory activity of quercetin from Calluna vulgaris (L.) Hull. J Ethnopharmacol 2009; 121(1): 178-81.
[40]
Chen CR, Tan R, Qu WM, et al. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice. Br J Pharmacol 2011; 164(5): 1534-46.
[41]
Xu Q, Yi LT, Pan Y, et al. Antidepressant-like effects of the mixture of honokiol and magnolol from the barks of Magnolia officinalis in stressed rodents. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(3): 715-25.
[42]
Bilia AR, Gallori S, Vincieri FFSt. St. John’s wort and depression: efficacy, safety and tolerability-an update. Life Sci 2002; 70(26): 3077-96.
[43]
Butterweck V, Schmidt MSt. John’s wort: role of active compounds for its mechanism of action and efficacy. Wien Med Wochenschr 2007; 157(13-14): 356-61.
[44]
Butterweck V. Mechanism of action of St John’s wort in depression: what is known? CNS Drugs 2003; 17(8): 539-62.
[45]
Seol GH, Shim HS, Kim PJ, et al. Antidepressant-like effect of Salvia sclarea is explained by modulation of dopamine activities in rats. J Ethnopharmacol 2010; 130(1): 187-90.
[46]
Herrera-Ruiz M, García-Beltrán Y, Mora S, et al. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J Ethnopharmacol 2006; 107(1): 53-8.
[47]
Guzmán-Gutiérrez SL, Bonilla-Jaime H, Gómez-Cansino R, Reyes-Chilpa R. Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway. Life Sci 2015; 128: 24-9.
[48]
Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem Pharmacol 2000; 59(11): 1387-94.
[49]
Machado DG, Cunha MP, Neis VB, et al. Antidepressant-like effects of fractions, essential oil, carnosol and betulinic acid isolated from Rosmarinus officinalis L. Food Chem 2013; 136(2): 999-1005.
[50]
Machado DG, Bettio LE, Cunha MP, et al. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33(4): 642-50.
[51]
Sasaki K, El Omri A, Kondo S, Han J, Isoda H. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behav Brain Res 2013; 238: 86-94.
[52]
Zhou K, Jia N, Jiang N, Wang F, Kou J. Beneficial effect of Danggui-Shaoyao-San, a traditional Chinese medicine, on drowsiness induced by chronic restraint stress. Neurosci Lett 2015; 597: 26-31.
[53]
Kou J, Zhu D, Yan Y. Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-san on aged mice. J Ethnopharmacol 2005; 97(2): 313-8.
[54]
Huang Z, Mao QQ, Zhong XM, et al. Mechanistic study on the antidepressant-like effect of danggui-shaoyao-san, a chinese herbal formula. Evid Based Complement Alternat Med 2012; 2012
[55]
Qiu F, Zhong X, Mao Q, Huang Z. The antidepressant-like effects of paeoniflorin in mouse models. Exp Ther Med 2013; 5(4): 1113-6.
[56]
Cassani J, Dorantes-Barrón AM, Novales LM, Real GA, Estrada-Reyes R. Anti-depressant-like effect of kaempferitrin isolated from Justicia spicigera Schltdl (Acanthaceae) in two behavior models in mice: evidence for the involvement of the serotonergic system. Molecules 2014; 19(12): 21442-61.
[57]
Ofir R, Tamir S, Khatib S, Vaya J. Inhibition of serotonin re-uptake by licorice constituents. J Mol Neurosci 2003; 20(2): 135-40.
[58]
Dhingra D, Sharma A. Antidepressant-like activity of Glycyrrhiza glabra L. in mouse models of immobility tests. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30(3): 449-54.
[59]
Biswas UK, Choudhry B, Amrita K. Comparative Evaluation Of The Antidepressant Effects Of Ethanolic And Aqueous Extract Of Glycyrrhiza Glabra In Rats And Mice.JGTPS. 2012; 3: pp. (1)585-601.
[60]
Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr 2007; 157(13-14): 315-9.
[61]
Berger F, Hensel A, Nieber K. Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices. Neuroscience 2011; 180: 238-47.
[62]
Ittiyavirah SP, Paul M. In silico docking analysis of constituents of Zingiber officinale as antidepressant. J Pharmacognosy Phytother 2013; 5(6): 101-5.
[63]
Singh RP, Jain R, Mishra R, Tiwari P. Antidepressant activity of hydroalcoholic extract of Zingiber officinale. IRJPAS 2012; 3(2): 149-51.
[64]
Uebelhack R, Franke L, Schewe HJ. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava). Pharmacopsychiatry 1998; 31(5): 187-92.
[65]
Seitz U, Schüle A, Gleitz J. [3H]-monoamine uptake inhibition properties of kava pyrones. Planta Med 1997; 63(6): 548-9.
[66]
Gabriela GC, Javier AA, Elisa VA, Gonzalo VP, Herlinda BJ. Antidepressant-like effect of Tagetes lucida Cav. extract in rats: involvement of the serotonergic system. Am J Chin Med 2012; 40(4): 753-68.
[67]
Gabriela GC, Javier AA, Elisa VA, Gonzalo VP, Herlinda BJ. Antidepressant-like effect of Tagetes lucida Cav. extract in rats: involvement of the serotonergic system. Am J Chin Med 2012; 40(4): 753-68.
[68]
Low Dog T, Powell KL, Weisman SM. Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief. Menopause 2003; 10(4): 299-313.
[69]
Kligler B. Black cohosh. Am Fam Physician 2003; 68(1): 114-6.
[70]
Szafrański T. Zastosowanie szafranu (crocus sativus)w psychiatrii. Przegląd piśmiennictwa. Psychiatria, wydanie specjalne 2013.
[71]
Xu Y, Wang C, Klabnik JJ, O’Donnell JM. Novel therapeutic targets in depression and anxiety: Antioxidants as a candidate treatment. Curr Neuropharmacol 2014; 12(2): 108-19.
[72]
Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HK. Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacol Biochem Behav 2003; 75(4): 823-30.
[73]
Yuan X, Chapman RL, Wu Z. Analytical methods for heavy metals in herbal medicines. Phytochem Anal 2011; 22(3): 189-98.
[74]
Malik J, Szakova J, Drabek O, Balik J, Kokoska L. Determination of certain micro and macroelements in plant stimulants and their infusions. Food Chem 2008; 111(2): 520-5.
[75]
Brima EI. Toxic elements in different medicinal plants and the impact on human health. Int J Environ Res Public Health 2017; 14(10)
[76]
Nasri H. Herbal drugs and new concepts on its use. J Prev Epidemiol 2016; 1(1)e01
[77]
Asgari A. Herbal medicines and kidney; friends or foes? J Nephropharmacol 2014; 3(1): 5-6.
[78]
Khodadadi S, Rafieian-Kopaei M. Herbs, health and hazards; a nephrology viewpoint on current concepts and new trends. Ann Res Antioxid 2016; 1(1)e05
[79]
Jafari T. Antioxidants; helpful or harmful? Ann Res Antioxid 2016; 1(2)e13
[80]
Fallah S, Rostaei M, Lorigooini Z, Surki AA. Chemical compositions of essential oil and antioxidant activity of dragonhead (Dracocephalum moldavica) in sole crop and dragonhead-soybean (Glycine max) intercropping system under organic manure and chemical fertilizers. Ind Crops Prod 2018; 115: 158-65.
[81]
Amiri A, Amiri A. Antioxidants and disease prevention; an obscure association with great significance. Ann Res Antioxid 2017; 2(1)e02


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 6
Year: 2019
Page: [738 - 745]
Pages: 8
DOI: 10.2174/1381612825666190402105803
Price: $65

Article Metrics

PDF: 40
HTML: 15
PRC: 1